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Abstract
Background: Calcifications of atherosclerotic plaques represent a controversial issue as they either lead to the
stabilization or rupture of the lesion. However, the cellular key players involved in the progression of the calcified
plaques have not yet been described. The primary reason for this lacuna is that decalcification procedures impair
protein and nucleic acids contained in the calcified tissue. The aim of our study was to preserve the cellular content
of heavily calcified plaques with a new rapid fixation in order to simplify the study of calcifications.
Methods: Here we applied a fixation method for fresh calcified tissue using the Carnoy’s solution followed by an
enzymatic tissue digestion with type II collagenase. Immunohistochemistry was performed to verify the preservation
of nuclear and cytoplasmic antigens. DNA content and RNA preservation was evaluated respectively with Feulgen
staining and RT-PCR. A checklist of steps for successful image analysis was provided. To present the basic features
of the F-DNA analysis we used descriptive statistics, skewness and kurtosis. Differences in DNA content were
analysed with Kruskal-Wallis and Dunn’s post tests. The value of P < 0.05 was considered significant.
Results: Twenty-four vascular adult tissues, sorted as calcified (14) or uncalcified (10), were processed and 17 fetal
tissues were used as controls (9 soft and 8 hard). Cells composing the calcified carotid plaques were positive to
Desmin, Vimentin, Osteocalcin or Ki-67; the cellular population included smooth muscle cells, osteoblasts and
osteoclasts-like cells and metakaryotic cells. The DNA content of each cell type found in the calcified carotid artery
was successfully quantified in 7 selected samples. Notably the protocol revealed that DNA content in osteoblasts in
fetal control tissues exhibits about half (3.0 ng) of the normal nuclear DNA content (6.0 ng).
Conclusion: Together with standard histology, this technique could give additional information on the cellular
content of calcified plaques and help clarify the calcification process during atherosclerosis.
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Background
Considered for decades a passive process, calcification is
now seen as an active mechanism sharing many similarities
with embryonic bone formation [1, 2]. The most recent
mechanism proposed to elucidate arterial calcification is
the possible role of resident or circulating stem cells that
differentiate into chondro-osteogenic cells [3]. Nowadays,
the clinical impact of arterial calcification is still unclear [4];
indeed the extent of calcification is associated with either a
good or bad prognosis. For example, in the coronary arter-
ies small calcifications increase the risk of plaque rupture
whereas bigger deposits seem to stabilize the plaque [5].
On the other hand, calcified carotid plaques are considered
a low athero-embolic risk [6]. In our recent study, we ob-
served that plaques with massive calcifications showed the
same incidence of histological complications but without
influencing clinical symptomatology [7].
A big issue in analysing calcified plaques is the deterior-
ation of the carotid tissues due to the strong pre-treatment
used to dissolve minerals (ethylenediaminetetraacetic acid
(EDTA) or chloride acid (HCl) prior to histopathological
processing [8].
Previous studies attempted to process calcified tissue
with alternative decalcification solutions or treatments
as ultrasound, however the major issue was maintaining
the whole cellular morphology together with an intact
DNA content [9, 10]; indeed the use of strong acids hy-
drolyses the DNA molecule. We hereby apply a parallel
approach to standard histology methods to preserve and
study the cellular content of heavily calcified plaques.
Our aim was to validate and optimized the techniques
for the study of calcified arterial tissues. Additionally to
calcified plaques, the technique was also tested on a
wide series of tissues from soft to hard (bone).
Methods
Tissue sampling
All samples were obtained under a protocol approved in
advance by the Massachusetts Institute of Technology,
Committee on the Use of Humans as Experimental
Subjects. No persons, including minors/children, were en-
rolled in MIT studies. Only surgical discards from patients
anonymous to MIT researchers were received from collab-
orating hospitals. These comprised fixed tissues from a var-
iety of organs. The Massachusetts Institute of Technology
IRB reviewed and approved the several collaborative rela-
tionships specifically indicating that the arrangements
were in the US NIH “exempt” category for the require-
ment for informed consent (COUHES approval number
0804002679). Anonymous surgical discards were fixed im-
mediately upon surgical removal in Carnoy’s solution as
described and stored under refrigeration in 70 % ethanol
[11]. A total of 41 tissue samples were finally collected
from 26 cases, 16 fetuses and 10 adults.
Experimental parameters were optimized for two differ-
ent types of samples, soft and hard. Hard adult samples
were defined as “undissectable” with standard procedures
without previous decalcification, commonly in Osteodec,
Bio-optical (EDTA, calcium’s chelates, 40 to 60 min
dependent on the tissue dimension). Of the 41 tissue sam-
ples retrieved, 22 were hard and 19 were soft, sorted in:
– 8 hard fetal samples; 3 femoral, 1 nasal bone, 1
elbow, 1 hip bone and 1 knee bone, and 1 chondroid
tissue.
– 9 fetal soft samples; 3 guts, 3 brains, 2 muscles, and
1 eye retinae.
– 14 hard adult samples; 13 calcified carotid plaques
and 1 calcified abdominal aortic aneurism.
– 10 soft adult samples; 9 uncalcified carotid plaques
and 1 uncalcified abdominal aortic aneurism.
Spreading method
All 41 tissue samples were fixed in cold Carnoy at
4 °C (3 ml Ethanol 100 % and 1 ml glacial acetic
acid per <0.25 cm2 within 30 min from surgical re-
moval. Carnoy solution was changed after 60 and
120 min for a total of 3 hours fixation. Sample were
then stored at -20 °C in 70 % ethanol [12]. Subse-
quent enzymatic tissue treatments with collagenase,
type II (Clostridium histolyticum, ≥200 collagenase
units/mg, Calbiochem, Merck Chemicals Ltd, UK)
were tested with different incubation times and concentra-
tions at 37 °C to define satisfactory conditions for various
tissue types (Table 1). The most notable requirement is the
need for up to 24 h of collagenase treatment to achieve
unfolding of the hard tissues.
Collagenase-treated tissue samples were subse-
quently macerated in 500 ul of 45 % acetic acid
(Table 1). Macerated tissue samples were minced with
surgical scissors creating pieces no greater than
0.3 mm in length. Each piece was transferred to a slide
Table 1 Specifications for satisfactory spreading of soft versus
calcified tissue samples in adult vascular tissues and fetal
samples
Type of
tissue
Collagenase II
digestion time
Collagenase II
working
concentrati
on (Ua/ml)
Acetic
acid 45 %
maceration
tIme
Spread
sections
size (max)
Adult hard 24 h 10U/1 ml 30 min 0.1 mm
Adult soft 18 h 10U/1.5 ml 10 min 0.3 mm
Fetal hard 12 h 10U/1.5 ml 20 min 0.2 mm
Fetal soft 1–4 h 10U/1.5 ml 10 min 0.3 mm
aOne CDU unit is defined as the amount of enzyme that will release 1.0 nmol
Leu equivalent from collagenase per min at 37 °C, pH 7.2
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in a drop of 45 % acetic acid. To spread the macerated
tissue into a monolayer, several thicknesses of filter
paper were placed on the coverslip and a tweezer han-
dle was moved steadily in one direction with a delicate
pressure. Intermittent microscopic examination during
the spreading process was used to determine when sat-
isfactory spreading had been achieved. Increased pres-
sure on the stacked filter paper was required for the
harder bone-containing samples. Cover slips were re-
moved after direct immersion in liquid nitrogen, and
slides were air dried for 1 h. Spread slides were stored
at 4 °C, in the dark, and subsequently used for differ-
ent forms of analyses: Von Kossa, Feulgen-Giemsa
staining, immunohistochemistry, Feulgen reaction for
DNA quantification and RNA extraction.
Histochemistry
Histochemistry included Von Kossa staining for the
identification of calcified matrix: sections were hydrated,
treated with 1.5 % silver nitrate (AgNO3) solution and
placed in front of a 100 W lamp for 1 h. Sections were
therefore rinsed in distilled H2O (dH2O), counterstained
with nuclear-fast Red, dehydrated and mounted.
The Feulgen-Giemsa staining was used to test the
preservation of the nuclei after the collagenase digestion
and the subsequent DNA quantification. Briefly, the
slides were placed in a Coplin jar filled with HCl 1 N at
60 °C for 8 min, for partial hydrolysis of the macromole-
cules and DNA depurination. Hydrolysis was stopped by
washing the slides in cold dH2O. After carefully drying,
sections were placed in Schiff ’s reagent (#3952016,
Sigma-Aldrich, St. Louis MO, US) for 1 h at room
temperature, washed twice with 2x standard saline cit-
rate (trisodium citrate 8.8 g/L, sodium chloride 17.5 g/L),
washed again with dH2O and thereafter counterstained
with 1 % Giemsa solution (#GS500, Sigma-Aldrich, St.
Louis MO, US) for 5 min. Slides were dehydrated in
graded step of alcohol and mounted with Canada Balsam
(Sigma- Aldrich C1795).
Feulgen DNA quantification
Feulgen densitometry relies on the premise that the
amount of stain bound to DNA is proportional to the
amount of DNA present in the nucleus with a 1:1 ratio.
Feulgen reaction is specific for DNA and does not stain
RNA [11, 13].
DNA quantification using Feulgen reaction (without
Giemsa) was carried out in 3 fetal and 4 adult samples,
each equally distributed as hard and soft areas (Table 2,
raw data are included in the Additional file 1). Nuclei of
chicken red blood cells (cRBC, #IC05-0810, Innovative
Research, Novi, MI, US) were used as an internal standard
for DNA quantification (one nucleus of RBC contains a
diploid quantity of DNA equivalent to 2C = 2.5 pg). Slides
are Feulgen stained in groups (25 to 100 slides) with the
same reagents, lots, conditions and standards. Image ac-
quisition and segmentation were performed with the Carl
Zeiss Vision AxioVision software: these are the critical
steps for a precise DNA quantification. All steps are
presented in details in the Additional file 2. The measure
features for each nucleus are the densitometric sum, the
densitometric area and the densitometric standard de-
viation. The quantity of stain is determined based on
the absorbance (Optical Density OD) evaluated by the
transmitted light (T).
OD ¼ log10 1=Tð Þ ð1Þ
As nuclear DNA stain is heterogeneous, a single point
(OD) would not be representative. Thus it is necessary
Table 2 Descriptive statistics for Feulgen-DNA content and mean nuclear area
Origin Cell type Nuclei Nr Skewness Kurtosis DNA pg SD Mean μm2 SD CV SE CI
1 Adult Hard 137 0.4 -0.6 6.0 3.1 72.7 36.9 50.8 % 3.2 66.5–79.0
2 Adult Soft 306 1.1 1.8 4.3 2.1 57.5 25.9 45.2 % 1.5 54.6–60.4
3 Adult Soft 48 1.4 2.8 5.6 2.2 66.1 24.7 36.8 % 3.5 59.0–73.1
4 Adult Soft 92 0.6 0.5 7.0 2.8 68.4 27. 40.4 % 2.9 62.7–74.1
5 Fetus Hard 145 1.6 2.7 3.1 1.6 46.9 25.3 53.9 % 2.1 42.7–51.0
6 Fetus Hard 46 1.5 1.7 1.7 0.9 31.4 16.8 53.5 % 2.5 26.4–36.3
7 Fetus Soft 120 1.1 0.5 4.8 2.4 63.8 32.7 51.2 % 2.9 57.9–69.7
Total 894 59.2 30.2 51.1 % 1.0 57.2–61.2
cRBC Control 339 -0.1 1.2 2.5a 25.9 5.9 22.6 % 0.3 25.3–26.5
SD standard deviation, CV coefficient of variation, SE standard error, CI confidence interval. Characteristics’ of samples: 1, calcified atherosclerotic carotid; 2, soft
atherosclerotic carotid; 3, healthy carotid; 4, abdominal aortic aneurism: 5, Femoral bone 11 weeks; 6, chondroid tissue 14 weeks; 7, fetal aorta 15 weeks
aConstant known quantity of DNA for the standard cRBC (the chicken red blood cells used as internal standards in each sample). Raw data are presented in the
Additional file 1
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to evaluate the whole nucleus as the integrated optical
density (IOD):
IOD ¼
X
i¼1
n
log10 1=Tið Þ ð2Þ
The scale of each image was 95.04 pixel/ μm2. Add-
itionally to nuclear IOD, the measured features were the
nuclear area (μm2) and the total number of nuclei
evaluated.
Calculation of genome size DNA
To convert IOD in genome size in pg we used the pri-
mary standard of RBC (1 C = 1.25 pg). Smears were
processed with the same way as samples and were in-
cluded in each experiment. To calculate DNA content a
standard curve (IOD vs known C-value) was generated
and used to verify that the stain was accurate:
DNA pg per nuclei in sample ¼ 2:5 pg = mean IOD standard
x IOD sample
Immunohistochemistry technique on Carnoy-fixed spread
tissue
Table 3 summarizes the antibody characteristics and the
blocking/antigen unmasking procedures used. Indeed,
due to the Carnoy fixation, some modifications in the
antigen retrieval procedures were optimized.
In addition to Von Kossa staining, immunostaining for
Ostecalcin (OCN) was used to spot the main compo-
nents of the bone matrix as well as the osteoblasts.
Samples were immunostained for Ki-67 antigen in
order to assess the chromatin preservation after the pro-
cedure and the cell proliferation. Finally, in order to ver-
ify the preservation of specific cytoplasmic antigens,
Desmin and Vimentin immunostaining was performed.
Carnoy-fixed spread tissue was rehydrated through
graded steps of ethanol absolute (100 %, Methanol 3 %
H2O2, 95 %, 70 %, H2O). Endogenous peroxidase activity
was neutralized with 3 % H2O2 in absolute methanol at
room temperature (rt), in the dark. Antigen-antibody
reaction was developed with the NovoLink® Polymer
Detection Kit (Novocastra, Newcastle, UK). To reduce
nonspecific antibody bindings, hydrophobic binding sites
were blocked with Casein 0.4 % (Novolink Protein
Block). Sections were incubated 1 h in a wet chamber at
rt with the primary antibodies.
To detect primary antibody bound to tissue, sections
were incubated with NovoLink® Polymer (8 mg/L) for
30 min at rt. Spreadings were further incubated with
chromogen/substrate, 3,3 - diaminobenzidine NovoLink®
(DAB pre-diluted 1:20), 30 s for fetal tissue and 2 min
for adult tissue, at rt, Cell nuclei were counterstained
with Mayer’s haematoxylin (Sigma Chemicals). Fetal tis-
sue was used as positive controls [12]. As negative con-
trols primary antibodies were omitted. Washing steps
were all performed with PBS. After dehydration in
graded steps of ethanol, samples were mounted onto
glass slides using Canada Balsam (Sigma-Aldrich
C1795). The sections were observed under a light micro-
scope (Axio Imager Z1 Zeiss, Germany) connected with
a charge-coupled device (CCD) camera.
RNA content: RT-PCR
RNA extraction
The RNA was extracted from Carnoy fixed spread sections
(monolayer). A commercial kit was used for RNA extrac-
tion (RNeasy® FFPE, Cat No. 73504, QIAGEN GmbH,
Hilden, Germany); the protocol was slightly modified to in-
crease RNA yield and purity. Spread tissue was recovered
from the slides with a scalpel by adding 5 μl of Proteinase
K buffer (PKD), under RNase free conditions. Retrieved tis-
sues were combined into a single nuclease-free screw cap
tube, dissolved in 245 μl of PKD and followed by centrifu-
gation for 1 min at 10 000 rpm. For cell lysis, we added
Table 3 Technical characteristics of the antibodies used for imunohistochemistry
Antibodies Type Antigen specifications Company Locus-Clone Dilution Endogenous
peroxidase
blocking
Antigen unmasking
treatment
Ki-67 Mouse
Monoclonal
Perichromosomal layer
protein. Identifies cells in
G1-S-G2-M phases.
Dako A/S, Copenhagen,
Denmark
10q26.2 MIB-1 1:100 20 min Citrate Buffer, heat mediated
(4 cycles 750 W, 5 min each)
Osteocalcin Rabbit
Polyclonal
Bone specific protein.
Synthesized by osteoblasts,
accumulates in the bone
matrix.
Millipore USA 1p22 1:100 30 min Tryton 0.5 % 4 min
Desmin Mouse
Monoclonal
Muscle specific
intermediate filament type
III protein.
Millipore USA 2q35 D33 1:100 20 min Citrate Buffer, heat mediated
(4 cycles 750 W, 5 min each)
Vimentin Mouse
Monoclonal
Intermediate filament type
III protein expressed in
mesenchymal cells.
Millipore USA 10p13 V9 1:80 20 min Not required
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20 μL of protease K; the mixture was incubated for 30 min
at 56 °C, mixed at 850 rpm, and then incubated again at
80 °C for 15 min. The protocol was followed as stated by
manufacturer’s instruction. Finally the RNA was eluted in
22 μl of RNAse free-water, heated at 65 °C for 5 min in
order to be denatured and to inactivate RNases, and stored
at -80 °C until used. RNA integrity and concentration
were measured by using an ND-1000 spectrophotometer
(NanoDrop, Fisher Thermo, Wilmington, DE, USA). The
ratio of the readings at 260 nm and 280 nm (A260/A280)
provides an estimate of the purity of RNA with respect to
the contaminants that absorb in the UV spectrum, such as
protein. Pure RNA has an A260/A280 ratio of 1.9–2.1.
RT-PCR assay
To assess the possibility of extracting RNA from Carnoy-
fixed spread tissue as template for retrotranscription and
gene expression, we amplified by RT-PCR the housekeep-
ing gene beta-glucuronidase (GUSB) for both femur bone
and intestine. GUSB is considered an housekeeping gene
required for the maintenance of basic cellular function
and expressed in all cells [14].
We also amplified the transcription factor Osterix
(OSX) essential for osteoblast differentiation and bone for-
mation [15] and the carcinoembryonic antigen-related cell
adhesion molecule 5 (CEACAM 5) normally produced in
gastrointestinal tissue during fetal development [16].
The reverse transcription assay was performed using
2 μg of total RNA per 20 μl of mix, following the manu-
facturer’s protocol (High capacity cDNA Archive kit,
Applied Biosystem). The cDNA was stored at -20 °C
until RT-PCR was performed. RT-PCR was carried out
following MasterMix TaqMan® Protocol (TaqMan Univ
PCR MasterMix, Applied Biosystems). Two μl of neat
cDNA were amplified using specific probes for GUSB
(NM_000181.3), CEACAM5 (NM_004363.2) and Osterix
(NM_001173467.1) in the RT-PCR mix (TaqMan® Gene
Expression Assay, Applied Biosystems, respective ID assay:
Hs00939627_m1, Hs00237075_m1, Hs00541729_m1).
Reactions were run on ABI PRISM 7900HT Sequence
Detection System (Applied Biosystems). The cycling condi-
tions were performed as follows: 10 min at 95 °C, 45 cycles
at 95 °C for 15 s and 60 °C for 60 s. Each assay was carried
out in triplicate and the transcription level was normalized
using GUSB as a reference gene. The threshold was set at
0.2 in order to be in the exponential phase. The values were
expressed as DCT (= >CT Target −CT GUSB).
Statistics
To present the basic features of the F-DNA analysis we
used descriptive statistics: mean, standard deviation, co-
efficient of variation, standard error, confidence interval
stated at 95 %, skewness and kurtosis. Differences in
DNA content in pg and fluctuations of DNA (expressed
as DNA content variation, DCV) [17] between samples
were analysed with Kruskal-Wallis (non parametric-
unmatched) and Dunn’s post tests. The value of P < 0.05
was considered significant.
Results
Immunohistochemistry
Samples of all 41 tissues specifically including the 22
“hard” tissues containing calcified sections were satisfactor-
ily spread for further analyses. Methods of decalcification,
i.e. EDTA treatment, was required in tissue processed with
the standard procedure but was not required in the spread
method using collagenase.
The Fig. 1 compared the results obtained with EDTA
treatment (Fig. 1a and b) versus collagenase digestion of a
calcified carotid artery (Fig. 1d and e). Fig. 1a showed a
Haematoxylin-Eosin section of calcified artery fixed in car-
noy, embedded in paraffin and decalcified with EDTA. Pre-
cipitates of calcium were very basophilic so calcification
areas were easily visible in violet (asterisk in Fig. 1). In the
insert of figure A, we also noticed an empty area (white
asterisk), where the calcified material was lost. Figure 1b
showed the same tissue of Fig. 1a immunostained for osteo-
calcin. The Fig. 1c showed the standard section fixed in
formalin, EDTA treated and stained for Osteocalcin, while
Fig. 1d and e displays the same tissue treated with
collagenase and stained for Osteocalcin. The immunohisto-
chemistry (IHC) for Osteocalcin evidenced osteoblasts
and synthesized matrix in the adult calcified artery (Fig. 1d
and e). All fetal cases and two calcified adult cases
showed multinucleated osteoclasts-like cells positive to
Osteocalcin. Von Kossa histochemical stain evidenced
the same calcified tissues in adult samples, but was
negative in fetal samples, where no osteogenic calcifica-
tion was present yet.
Antigen for cytoplasmic intermediates Desmin (Fig. 2)
and Vimentin (not shown) were found in all prepara-
tions. Desmin and Vimentin showed a reliable positivity
indicating that the collagenase digestion of samples and
the other treatments did not damage the cytoplasmic
intermediate filaments. Figure 2a and B show the good
preservation of the smooth muscle cells expressing
Desmin in the spread tissue. IHC for Ki-67 confirmed
also the good preservation of the chromatin in the
spread tissue (Fig. 3c-f). Surprisingly, Ki-67 was also de-
tected in some cells in heavily calcified tissues: for ex-
ample, case #1 (calcified atherosclerotic carotid, Fig. 3a)
was described as acellular during routine IHC analysis
by means of standard 2.5 μM sections. However, the
monolayer IHC analysis revealed the presence of a het-
erogeneous population of cells (Fig. 3b), including Ki-67
positive cells (Fig. 3c and d). Mitotic figures were easily
spotted with ki-67 staining (Fig. 3d). To verify the speci-
ficity of ki-67 staining in the spread artery, a tissue with
Fittipaldi et al. BMC Clinical Pathology  (2016) 16:12 Page 5 of 11
a high rate of proliferative cells (fetal tissues) was
selected and stained with ki-67 (Fig. 3e-f ).
Nuclear DNA content of spread tissues
The Feulgen DNA quantification was performed in the 7
cases listed in Table 2: a total of 894 nuclei were evalu-
ated for IOD and nuclear areas. Overall sample mean
IOD was 2.3 ± 1.3 × 10^7, overall mean nuclear area was
59.2 ± 30.2 μm2. In the standard cRBC a total of 339
nuclei were examined: mean IOD was 1.2 ± 0.3 × 10^7,
mean nuclear area was 25.9 ± 5.9 μm2. Feulgen absolute
DNA content was successfully calculated in all 7 cases,
both soft and hard tissues. In particular, the heavily cal-
cified carotid artery lesion (case #1), had a mean DNA
quantity of 6.0 pg, concomitant with the known DNA
diploid content of human cells (2C = 6 pg) (Fig. 4a,
Table 2). Kurtosis and skewness analysis showed that
samples had a unimodal, near-Gaussian distribution of
the diploid F-DNA (2C) (Table 2, Fig. 4a). The nuclear
size was directly proportional to the DNA content of the
cells in the 7 cases. Indeed, Fig. 4b shows that the quan-
tity of DNA within each cell of the calcified carotid
Fig. 1 Adult calcified carotid artery sections EDTA treated (a-b-c) and collagenase treated (c-d). a Haematoxylin-Eosin (HE) staining of a standard
section fixed in carnoy and EDTA treated (scale bar 40 μm). The insert in figure a shows the whole arterial section with a diameter of 4 mm,
* asterisks highlights the calcified areas. b osteocalcin immunostain of the same tissue fixed in carnoy (scale bar 20 μm) or (c) fixed in formalin
(scale bar 10 μm). d-e Osteocalcin immunostaining of the collagenase treated tissue fixed in carnoy. d positive osteoblast and (e) positive
osteoclast-like cells, scale bar 5 μm. Nucleus and cytoplasmatic structure are clearly visible in collagenase spread tissue compared to standard
section (a and b)
Fig. 2 Desmin IHC staining in spread fetal tissue. a group of desmin positive smooth muscle cells (SMC) and (b) a single SMC in the fetal bowel
crypts. *SMC are indicated by a white asterisk and showed the typical elongated “cigar-shaped” nuclei. The SMC along the crypts show a
moderate to strong cytoplasmatic staining reaction, scale bar 10 μm
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artery (#1) was significantly proportional to the area of the
nucleus (R2= 0.97, Pearson correlation p < 0.0001). This
means that there is a good preservation of the nuclear struc-
tures also in the heavily calcified tissues after the procedure.
Adult and fetal tissues showed a significant DNA con-
tent variation (DCV, Table 2) within cells, except for
DNA content in soft healthy adult arteries (#3, 5.6 pg,
CV 36.8 %) compared to DNA content in fetal aortic
cells (#7, 4.8 pg, CV 51.2 %). Both samples contained a
homogenous population of smooth muscle cells. Of
note, soft tissue from healthy carotid arteries #3 had the
lowest adult CV (5.6 pg, 36.8 %). DCV significantly dif-
fers between pathological atherosclerotic soft arteries
(45.2 %) and calcified arteries (50.8 %). Highest DCV
were found in all fetal tissues (range 51.2 to 53.9 %).
In particular, two cases showed significant unexpected
lower mean DNA content per nucleus compared to adult
samples; case #5 (fetal femoral bone) with 3.1 ± 1.6 pg and
case #6 (chondroid tissue) with 1.7 ± 0.9 pg (p < 0.0001,
Table 2, Fig. 4c). In those cases we decided to perform de-
tailed analyses of the DNA in each single cell composing
the tissues (the AxioVision software marked each nucleus
with a single identification number corresponding to its
IOD). We noticed that case #5 was mainly composed of
osteoclasts and case #6 of syncytia (Fig. 4d and e). By
measuring the DNA content per nucleus we observed un-
expected results. Nuclei outside osteoclasts and syncytial
formations showed a constant DNA content of 6 pg. In
osteoclasts, DNA content per nucleus ranged from 2 to
3 pg. In the syncytia formations, nucleus showed a DNA
content ranging from 1 to 2 pg per nucleus. Surprisingly
the mean DNA content per syncytium (sum of nuclear
DNA nucleus in the whole syncytia) was 6.6 ± 1.4 pg.
RNA preservation (RT-PCR)
Additionally to the housekeeping gene GUSB, we evalu-
ated the expression of CEA for intestinal fetal tissue and
Osterix for calcified/osteogenic tissues. The total mean
extracted mRNA from fetal intestine tissue (FI) and
femur bone (FB) was 7374 ng and 1430 ng respectively.
A260/A280 ratio was 1.94 for both fetal intestine and
fetal bone showing the absence of contamination of the
RNA extracted (standard ratio range from 1.9 to 2.1).
The mean threshold cycle (CT) values of endogenous
control GUSB were 30.34 ± 0.18 in FI and 37.34 ± 0.24 in
FB. Mean CT for tested gene OSX and CEA were
38.52 ± 0.10 and 35.34 ± 0.31 respectively. ΔCT CEA and
ΔCT OSX were 5.02 and 1.18 respectively (Table 4).
Additional cellular component observed in arteries
Figure 5a shows a standard histological staining of the
carotid plaques section (#1); of note the rupture of the
endothelium (marked with an asterisk) and the presence
of extensive calcification. However, the spread of the
same sample (#1) allowed the identifications of a
disclosed and complex cellular content. Besides the
majority of the cells that have a spindle shaped nucleus
(Fig. 3b), cells with a particular balloon shaped nucleus
were identified in the calcified carotid plaque (in 2 cases,
Fig. 5b and c). Also, we noticed that Ki-67 antigen
stained some of the metakaryotic nuclei in the mono-
nuclear forms (data not shown). The same cells were
also arranged in a tubular form that reminds syncytial
structure (Fig. 5d). In syncytium, Ki-67 highlighted only
the cells located in the extremities (Fig. 3e and f) and
nuclei inside syncytia were negative to Ki-67. This type
of cells, named metakaryotic cells [12], with a typical
Fig. 3 Ki-67 IHC staining in spread tissues. a adult calcified artery fixed in Carnoy, length of 1.5 cm. b Haematoxylin staining and (c-d) the
corresponding ki-67 staining of the calcified artery at low magnification (inserts) and higher magnification. e-f positive control for Ki-67 nuclear
immunostain (fetal bowel tissue), scale bar 25 μm
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hollow bell-shaped nucleus, was found in our study in
all fetal tissues both in the syncytial form (Fig. 5d) and
in the mononuclear form (Fig. 5e) while in the adult
arteries, these cells were spotted in 6 cases.
Discussion
The spreading technique showed a good reproducibility
and accuracy in the evaluation of cell protein expression
and single-cell DNA content in calcified carotid arteries.
The IHC markers were selected in order to check the in-
tegrity of the different cellular compartments: nucleus
(Ki-67) and cytoplasm (Desmin, Vimentin, Osteocalcin).
To verify the reliability of the techniques we used fetal
tissues sample as positive control since this tissue was
already validated [12]. As standard for the Feulgen DNA
quantification we chose cRBC, since they are convenient,
easy to isolate and they have a constant known DNA
Table 4 Threshold cycle (Ct) values for GUSB, OSX and CEA in
fetal tissues
Threshold cycle values
Micro-dissected
sample
β-glucuronidase
GUSB
Osterix OSX Carcino-embryonic
antigen CEA
Fetal femur bone
12w
37.06 38.42 -
37.50 38.63
37.45 38.51
Fetal intestine
9w
30.03 - 35.70
30.32 35.15
30.37 35.17
Fig. 4 Feulgen DNA analysis (a) Unimodal distribution of Feulgen-DNA content expressed as fold DNA content (interrupted lines designate modal
positions of diploid 2C), (b) Relation between DNA content and nuclear area (c) Feulgen DNA quantity (pg) in fetal tissues and (d-e) examples of
the images used for F-DNA quantification. d fetal femoral bone femur osteoclasts (#5), (e) fetal femoral bone cartilage syncytia (#6), scale
bar 5 μm
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content [18, 19]. Our results confirmed the reliability of
the standard as cRBC genome size was proportional to
the area of the cells and CV% was low (23 %). The diges-
tion times with collagenase requested by the spreading
technique varied considerably according to the different
tissues (see Table 1). Nevertheless, the adult and fetal
DNA content distribution curves were all Gaussian with
the same trend, showing that collagenase did not influ-
ence the DNA content, regardless the digestion times.
The Carnoy-fixed spread tissue also allows to extract
preserved RNA, without any contaminations by proteins
or phenols, and the sigmoid-shaped curves obtained at
RT-PCR showed a typical PCR gene amplification.
The technique could also give new information regard-
ing the study of calcification and osteogenesis. Usually
DNA quantity is evaluated in the whole tissue; unfortu-
nately one disadvantage is the loss of information on the
single cell profile. Moreover standard decalcification
procedures degrade the DNA content in calcified arter-
ies. First this protocol avoids the use of formalin to fix
the arteries and also avoids the use of strong acid to de-
calcify the arteries. This allows extracting directly from
the slides of spread tissue the RNA and DNA and evalu-
ates the gene expression in calcified tissues from a very
small quantity of sample. Moreover the protocol pre-
served the morphology of the nucleus and allowed the
visualization of the nuclear organization. As already
reported, some cases of atherosclerotic carotid tissues
contain bone lacunae-like mature structure in develop-
ment with lamellar bone. In these cases, the protocol is
of great help to open the “core” of the bone structure
and visualize the cellular content. It is very difficult with
the standard histological techniques to obtain a mono-
layer of cells. Surprisingly our data revealed and con-
firmed that the calcified part of arteries contains a
heterogeneous population of cells composed by smooth
muscle cells, osteoclasts-like cells and osteoblasts. More-
over the IHC revealed that some of the cells, composing
the core of the calcification, were actively dividing. The
observation is in line with other studies suggesting that
arterial calcification is an active process [5].
Feulgen on calcified arteries spread allows spotting the
peculiarity of the single cell. For example, we observed
that two cases of fetal bone (#5 and #6) showed the low-
est DNA absolute quantities. By reviewing the literature
only a few groups spotted this paradox in DNA content.
Solari et al. reported that osteoclasts undergo amitotic
division by a budding mechanism in vitro [20]. Then
Sundaram in 2004 demonstrated the existence of a
set of cells dividing through neosis [21] and in 2014,
Thilly et al. showed that the cells in syncytia divide by an
amitotic mechanism with a dsRNA/DNA intermediate
[22]. As Feulgen only stains DNA and not RNA [11, 13]
we can hypothesize that the nuclei in the syncytia of fetal
Fig. 5 Standard 2.5 μm sections and collagenase spread of calcified tissues. a Haematoxylin-Eosin staining of adult calcified carotid arteries, scale
bar 400 μm. b-c Feulgen staining of spread tissue of adult calcified carotid arteries showing examples of metakaryotic nuclei. d-e Feulgen staining
of spread tissues showing nuclei in syncytium (fetal femoral tissue), scale bar 5 μm
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bone tissue undergo dsRNA/DNA intermediate during
replication, thus explaining the lower mean quantity of
DNA (1 pg to 3 pg) and the negativity to Ki-67.
Of fluctuations of DNA, defined as an increased range
of DNA content, were observed both in the cell populations
and within the single cells. The lowest CV variation was
found in the healthy soft sample (#3) characterized by a
homogenous population of SMC. Conversely the major CV
in adult tissue was counted in the calcified tissue. This is
likely to reflect a heterogeneous cell population in the fetal
and adult pathologic tissues, compared to the cytological
homogeneity of the smooth muscle cells in healthy arteries.
In conclusion, thanks to the preservation of the nuclear
morphology the technique allowed to disclose osteoclasts-
like cells and others cells type with a bell-shaped nucleus,
recognised as metakaryotic cells [23]. These particular
cells are very difficult to identify due to the loss of nuclear
morphology when using strong acid for decalcification.
Mainly studied in the progression of tumours [12], we can
hypothesis that these cells are also a key player in athero-
sclerosis [24].
Conclusion
The spread gently preserves the original morphology of
each single cell in the calcified vascular tissues. The pre-
sented protocol will be used to study the calcification or
osteogenic process occurring during atherosclerosis and
to evaluate the single cell DNA content on a large series
of calcified plaques. The opportunity to extract and
amplify intact nucleic acid from the cells of heavily calci-
fied arteries opens the possibility to study calcification on
a larger scale. This is not doable when arteries are treated
with decalcification reagents.
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